Experimental drug BNC210 shows early benefits in PTSD trial
Bionomics Limited is reporting that their experimental drug BNC210, a novel α7 nicotinic acetylcholine receptor modulator, ...
Why some concussions are worse than others
As organs go, the human brain is an odd one. It's remarkably big relative to our bodies, for starters. It's also wrinklier than most, with a complex, folded surface making space for the tens of ...
Only a third of U.S. kids have gotten flu shots, data reveal
Despite a record number of American children dying from the flu last year, the percentage of kids getting their flu shots ...
Non-tumor cells in pancreatic cancer may reduce the effectiveness of the body's natural immune response
The relationship the immune system and stromal cells in pancreatic cancer can have a significant impact on patients' survival ...
Trial finds quality of life similar among patients with low-risk DCIS whether they received active monitoring or surgery
Patients with low-risk ductal carcinoma in situ (DCIS) who underwent active monitoring reported comparable physical, ...
Universal health coverage is not an impossible goal
Africa must strengthen health systems through innovation and collaboration to achieve universal health coverage, write ...
COMET trial finds active monitoring is a viable option for some patients with low-risk DCIS
Among patients with hormone receptor (HR)-positive, HER2-negative, low-risk ductal carcinoma in situ (DCIS), those who ...
Unlocking the clock: The role of the circadian system in inflammatory bowel diseases
Inflammatory bowel diseases (IBDs), including Crohn's disease and ulcerative colitis, are marked by cycles of immune ...